[The Washington Post] How do you pay for a drug that costs $84,000?

“As longtime health-care advocate John Rother sees it, the Sovaldi issue is a turning point for the health-care system, making it confront the biggest questions: how we pay for drugs, how public health prioritizes treatments, how insurance is designed to make these drugs affordable for patients, and, ultimately, our societal obligation to ensure access to life-saving treatments. ‘This is a necessary drug for people who are sick, yet we’re allowing the price to impose an incredible barrier to access,’ said Rother on Tuesday during a panel discussion on specialty drugs hosted by Morning Consult.”